Impiricus proudly sponsored and participated in Pharma USA 2025, hosted by Reuters on March 18-19. The conference featured a panel discussion spearheaded by Impiricus, “Small Community Matters: Remote HCP Engagement Solved,” focusing on innovative strategies for engaging healthcare professionals (HCPs) in remote and rural areas.
Sandy Donaldson, CEO of Impiricus, joined a distinguished group of experts for the panel, including:
Julio Fernandez, Sr. Director, Medical Affairs, Oncology, Regeneron
Sana Ghafoor, Medical Director, Early Clinical Development, Pfizer
Matt Gunther, Group SVP, Engagement Strategy, CMI Media Group (Moderator)
The session, part of the Future Proof Track, addressed several critical topics:
- Reaching rural HCPs with clinical data to access new patient and customer ecosystems
- Addressing individualized challenges faced by community physicians
- Tailoring outreach to share expanded access to treatments
- Addressing inequalities in the US healthcare system
During the panel, Sandy Donaldson emphasized the importance of leveraging new technology to bridge gaps in healthcare access and improve patient outcomes in underserved communities. “Our goal is to ensure that every healthcare professional, regardless of location, has access to the latest clinical data and treatment options,” said Donaldson.
In addition to the panel discussion, the Impiricus partnerships team attended Pharma USA to explore innovative solutions for dynamic HCP engagement with clients and partners. This underscores the team’s commitment to advancing healthcare through collaboration and cutting-edge technology.
Pharma USA 2025 provided a platform for industry leaders to share insights, discuss challenges, and explore opportunities for improving healthcare delivery. Impiricus’s panel highlighted its dedication to addressing the unique needs of community physicians and enhancing healthcare access for all.
